Mer­ck halts Phase 3 tri­al with PAH drug Win­re­vair fol­low­ing pos­i­tive in­ter­im da­ta 

Mer­ck is stop­ping a Phase 3 tri­al of its pul­monary ar­te­r­i­al hy­per­ten­sion treat­ment Win­re­vair al­most a year ear­ly fol­low­ing pos­i­tive in­ter­im da­ta, the com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER